ReviewOncoTargets and therapy2021

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection.

Alexis LeVee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.